MODERN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

MODERN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Show other versions (1)

The review is devoted to modern pharmaceutical treatment of pulmonary arterial hypertension (PAH). In 1970-80s, it was based on high-dose calcium antagonists, CAs (e.g., nifedipine 240 mg/d), which were effective only in some patients with primary (idiopathic) PAH. CAs were combined with digoxin, in...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Preobrazhensky, B. A. Sidorenko, S. A. Pataraya, T. A. Batyraliev, Z. A. Niyazova-Karben, Mesut Ishlek
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-12-01
Series:	Российский кардиологический журнал
Subjects:	calcium antagonists prostanoids epoprostenol trepostinil iloprost bosentan sildenafil
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1409
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern pharmaceutical treatment of pulmonary arterial hypertension
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE
by: N. A. Shostak, et al.
Published: (2015-09-01)

UP-FRONT TRIPLE COMBINATION THERAPY FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A CASE REPORT
by: A. V. Volkov, et al.
Published: (2018-03-01)

Raynaud’s phenomenon in the rheumatologist’s practice
by: R.T. Alekperov
Published: (2014-05-01)

EFFICACY OF MULTIDISCIPLINARY MANAGEMENT OF PULMONARY HYPERTENSION
by: I. R. Gaisin, et al.
Published: (2017-02-01)

TACTICS FEATURES OF CONDUCTING AND CHOOSING SPECIFIC THERAPY FOR ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE
by: O. A. Arkhipova, et al.
Published: (2018-03-01)

New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations
by: T. V. Martynyuk, et al.
Published: (2010-04-01)

Clinical case of a patient with pulmonary capillary hemangiomatosis: rapid progression or lost time?
by: E. A. Devetyarova, et al.
Published: (2021-11-01)

How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
by: Ivan M. Robbins, et al.
Published: (2025-01-01)

Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial
by: Mandana Kashaki, et al.
Published: (2025-01-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
by: Gunlawadee Maneenil, et al.
Published: (2018-02-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

SUCCESSFUL MEDICATION THERAPY OF ACUTE RIGHT VENTRICLE INSUFFICIENCY IN RECIPIENT WITH SIGNIFICANT PULMONARY HYPERTENSION AFTER HEART TRANSPLANTATION
by: A. M. Chernyavskiy, et al.
Published: (2014-12-01)

Intravenous prostacyclin analogue iloprost (Ilomedin®) in the treatment of a patient with Buerger’s disease
by: Ilshat Ravilevich Gaisin, et al.
Published: (2013-03-01)

EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
by: O. M. Korolkova, et al.
Published: (2019-06-01)

Pulmonary hypertension syndrome in dilation cardiomyopathy patients: sildenafil application to common treatment of chronic heart failure
by: T. A. Abdullaev, et al.
Published: (2016-02-01)

Challenges in diagnosis and treatment of scleroderma renal crisis (clinical case report)
by: E. M. Mishina, et al.
Published: (2025-06-01)

The role of prostanoids in regulatory T cells and their implications in inflammatory diseases and cancers
by: Somsak Prasongtanakij, et al.
Published: (2025-06-01)

Comparison of Milrinone with Sildenafil for the Treatment of Persistent Pulmonary Hypertension of the Newborn
by: Imtiaz Ahmad, et al.
Published: (2024-06-01)

Comparison of Milrinone with Sildenafil for the Treatment of Persistent Pulmonary Hypertension of the Newborn
by: Imtiaz Ahmad, et al.
Published: (2024-06-01)

Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01)

PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: N. A. Shostak, et al.
Published: (2016-01-01)

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: D. A. Yakhontov, et al.
Published: (2016-01-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE
by: O. V. Gaisenok, et al.
Published: (2015-09-01)

FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW
by: L. I. Katelnitskaya, et al.
Published: (2016-01-01)

Effects of Sildenafil and Vitamin E on Paraquat-Induced Pulmonary Fibrosis in Rats
by: Fouziyeh Siahpour, et al.
Published: (2024-12-01)

The Negative Impact of Sildenafil on Behavior and Psychology
by: Prashant Mahajan, et al.
Published: (2025-04-01)

Pediatric Use of Inhaled Iloprost
by: Stephanie S. Handler, et al.
Published: (2025-04-01)

Evaluation of the Vascular Effects of Iloprost in Patients with Thromboangiitis Obliterans (Buerger’s Disease)
by: Mehmet Ali Kayğın, et al.
Published: (2025-07-01)

IL-4Rα signalling influences behavioural and immune responses in Trypanosoma brucei-infected mice: Evidence for iloprost as a neuroprotective agent
by: OS Olaolu, et al.
Published: (2025-12-01)

CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY
by: R. I. Striuk
Published: (2016-01-01)

Histologic and genetic features of remodeling of tissue-engineered small-diameter vascular grafts: outcomes of six-month implantation in a sheep model
by: E. A. Senokosova, et al.
Published: (2024-07-01)

THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: V. M. Paramonov, et al.
Published: (2016-06-01)

Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
by: N. G. Pivonova, et al.
Published: (2009-08-01)